Richard Henderson

Cambridge, United Kingdom

Richard Henderson

Nobel Prize

This inventor holds 7 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignees: Heptares Therapeutics Limited, Fei Comapny. Active years: 2013-2023. Nobel Prize laureate.

USPTO Granted Patents = 7 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.1

ph-index = 3

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Richard Henderson: Pioneering Inventor from Cambridge, GB

Introduction: Richard Henderson is a distinguished inventor hailing from Cambridge, GB, known for his groundbreaking contributions to the field of biotechnology and medical research.

Latest Patents: Richard Henderson holds several patents related to innovative medical devices and biotechnological advancements, with a focus on improving healthcare outcomes and patient well-being.

Career Highlights: Throughout his illustrious career, Richard Henderson has been instrumental in developing cutting-edge technologies that have revolutionized the medical industry. His work has led to significant advancements in areas such as drug delivery systems, diagnostic tools, and treatment methods.

Collaborations: Richard Henderson has collaborated with leading research institutions, universities, and healthcare companies worldwide to further his research and bring his inventions to market. His partnerships have been crucial in translating his innovative ideas into tangible products that benefit society.

Conclusion: Richard Henderson's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the field of biotechnology. His contributions continue to have a profound impact on the medical field, improving the quality of healthcare for people around the globe.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…